Found: 18
Select item for more details and to access through your institution.
Evaluation of biomarker, behavioral, and immunostimulatory profiles following treatment with Class C CpG ODN in a non‐human primate model of sporadic CAA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.079072
- By:
- Publication type:
- Article
Age‐associated biomarker profiles in a non‐human primate model of sporadic CAA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080537
- By:
- Publication type:
- Article
The association between anxiety and Alzheimer's disease plasma biomarkers across stages.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080554
- By:
- Publication type:
- Article
Diagnostic of Novel Plasma Biomarkers in Controls, SCD and MCI Subjects.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075989
- By:
- Publication type:
- Article
FDA‐approved carbonic anhydrase inhibitors rescue brain Aβ overload, cerebrovascular pathology and gliosis in Alzheimer's disease model.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078985
- By:
- Publication type:
- Article
FDA‐approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 11, p. 5048, doi. 10.1002/alz.13063
- By:
- Publication type:
- Article
Carbonic anhydrase inhibitors: a novel pharmacological strategy to rescue Aβ‐induced neurovascular pathology and gliosis in vivo.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 3, p. 1, doi. 10.1002/alz.064284
- By:
- Publication type:
- Article
Comparison of serum neurodegenerative biomarkers among hospitalized COVID‐19 patients versus non‐COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 899, doi. 10.1002/alz.12556
- By:
- Publication type:
- Article
Evaluation of class C CpG ODN efficacy and safety profile in a squirrel monkey model of AD pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055028
- By:
- Publication type:
- Article
Plasma biomarkers of neurodegeneration and neuroinflammation in hospitalized COVID‐19 patients with and without new neurological symptoms.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057892
- By:
- Publication type:
- Article
Pharmacological inhibition of carbonic anhydrases ameliorates cognitive dysfunction, rescuing Aβ‐induced neurovascular pathology in vivo.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.054199
- By:
- Publication type:
- Article
Carbonic anhydrase inhibition ameliorates Aβ‐induced neurovascular dysfunction in vivo: Molecular and cell biology/vascular factors.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044221
- By:
- Publication type:
- Article
Associations between subjective cognitive decline (SCD) diagnosis and severity with plasma tau and NfL levels using SIMOA technology: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043886
- By:
- Publication type:
- Article
P4‐170: MITOCHONDRIA‐MEDIATED ENDOTHELIAL DYSFUNCTION IN AD AND CAA: MECHANISMS AND THERAPEUTIC STRATEGIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1339, doi. 10.1016/j.jalz.2019.06.3832
- By:
- Publication type:
- Article
P3‐464: CARBONIC ANHYDRASE INHIBITORS AMELIORATE NEUROVASCULAR DYSFUNCTION IN A MOUSE MODEL OF CEREBRAL AMYLOID ANGIOPATHY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1296, doi. 10.1016/j.jalz.2018.06.1828
- By:
- Publication type:
- Article
DIFFERENTIAL VALUE OF PLASMA TAU AS A BIOMARKER FOR ALZHEIMER'S DISEASE AND CHRONIC TRAUMATIC BRAIN INJURY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1307, doi. 10.1016/j.jalz.2017.06.1999
- By:
- Publication type:
- Article
Obstructive Sleep Apnea and Hypertension with Longitudinal Amyloid-β Burden and Cognitive Changes.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Carbonic anhydrase inhibition selectively prevents amyloid β neurovascular mitochondrial toxicity.
- Published in:
- Aging Cell, 2018, v. 17, n. 4, p. 1, doi. 10.1111/acel.12787
- By:
- Publication type:
- Article